Cargando…

COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A review

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible and pathogenic coronavirus responsible for the pandemic coronavirus disease 19 (COVID-19). It has significant impact on human health and public safety along with negative social and economic consequences. Vaccinat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarkar, Malay, Madabhavi, Irappa V., Quy, Pham Nguyen, Govindagoudar, Manjunath B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809131/ https://www.ncbi.nlm.nih.gov/pubmed/35198043 http://dx.doi.org/10.4103/atm.atm_404_21

Ejemplares similares

Vaccine-induced immune thrombotic thrombocytopenia
por: Klok, Frederikus A, et al.
Publicado: (2022)

Thrombocytopenia in COVID-19 and vaccine-induced thrombotic thrombocytopenia
por: Geronikolou, Styliani A., et al.
Publicado: (2022)

Digital clubbing
por: Sarkar, Malay, et al.
Publicado: (2012)

COVID-19 vaccine-induced immune thrombotic thrombocytopenia: a review
por: Suhaimi, Siti Nur Atikah Aishah, et al.
Publicado: (2023)

Vaccine-induced immune thrombotic thrombocytopenia
por: Kanack, Adam J., et al.
Publicado: (2022)

Vaccine-induced immune thrombotic thrombocytopenia
por: Cines, Douglas B., et al.
Publicado: (2023)

Auscultation of the respiratory system
por: Sarkar, Malay, et al.
Publicado: (2015)

Osteoporosis in Chronic Obstructive Pulmonary Disease
por: Sarkar, Malay, et al.
Publicado: (2015)

Multiple Subcutaneous Nodules Leading to Diagnosis of Colon Cancer
por: Madabhavi, Irappa, et al.
Publicado: (2018)

Physical signs in patients with chronic obstructive pulmonary disease
por: Sarkar, Malay, et al.
Publicado: (2019)

Exceptional Responder to Immunotherapy: A Rare Case of Post-HSCT DLBCL Relapse Responding to Nivolumab
por: Madabhavi, Irappa, et al.
Publicado: (2019)

Proximal Descending Thoracic Aortic Pseudoaneurysm Secondary to Pott's Spine
por: Madabhavi, Irappa, et al.
Publicado: (2020)

Pregnancy Outcomes in Chronic Myeloid Leukemia: A Single Center Experience
por: Madabhavi, Irappa, et al.
Publicado: (2019)

Vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Warkentin, Theodore E.
Publicado: (2022)

Recognizing Vaccine-Induced Immune Thrombotic Thrombocytopenia
por: Iba, Toshiaki, et al.
Publicado: (2021)

The rollercoaster of vaccine-induced immune thrombotic thrombocytopenia
por: Cliff, Edward R Scheffer
Publicado: (2022)

Immune-Mediated Platelet Activation in COVID-19 and Vaccine-Induced Immune Thrombotic Thrombocytopenia
por: Uzun, Günalp, et al.
Publicado: (2022)

Lessons from vaccine-induced immune thrombotic thrombocytopenia
por: Kelton, John Greenhow, et al.
Publicado: (2021)

Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Greinacher, Andreas, et al.
Publicado: (2022)

Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Gabarin, Nadia, et al.
Publicado: (2022)

Eltrombopag for refractory vaccine-induced immune thrombotic thrombocytopenia
por: Maraziti, Giorgio, et al.
Publicado: (2021)

Vaccine-induced immune thrombotic thrombocytopenia and patients with cancer
por: Connors, Jean M., et al.
Publicado: (2022)

NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia
por: Leung, Halina H. L., et al.
Publicado: (2022)

Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia
por: Bourguignon, Alex, et al.
Publicado: (2021)

COVID-19 Adenoviral Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT), COVID-19-Related Thrombosis, and the Thrombotic Thrombocytopenic Syndromes
por: Allas, Gewil Daniella Olipas, et al.
Publicado: (2022)

COVID-19 vaccine safety surveillance and emerging concerns of vaccine-induced immune thrombotic thrombocytopenia
por: Teo, Shyh Poh
Publicado: (2021)

A Case of COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia
por: Chittal, Abhinandan, et al.
Publicado: (2021)

A Case of COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia
por: Harrison, Hailey, et al.
Publicado: (2022)

The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia
por: Iba, Toshiaki, et al.
Publicado: (2022)

Imaging of Oxford/AstraZeneca® COVID-19 vaccine-induced immune thrombotic thrombocytopenia
por: Garnier, Matthieu, et al.
Publicado: (2021)

COVID-19 Vaccine-Induced Pro-thrombotic Immune Thrombocytopenia (VIPIT): State of the Art
por: Calcaterra, Giuseppe, et al.
Publicado: (2022)

A Study of Use of “PORT” Catheter in Patients with Cancer: A Single-Center Experience
por: Madabhavi, Irappa, et al.
Publicado: (2017)

Microvascular manifestations revealing vaccine-induced thrombotic thrombocytopenia after COVID-19 vaccination
por: Noyé, M., et al.
Publicado: (2022)

Perspectives on vaccine induced thrombotic thrombocytopenia
por: Dotan, Arad, et al.
Publicado: (2021)

Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia
por: Patriquin, Christopher J., et al.
Publicado: (2021)

Recognizing, managing and reporting vaccine-induced immune thrombotic thrombocytopenia
por: Sholzberg, Michelle, et al.
Publicado: (2021)

Tozinameran: Vaccine-induced immune thrombotic thrombocytopenia: case report
Publicado: (2022)

The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia
por: Bissola, Anna-Lise, et al.
Publicado: (2022)

Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis
por: Jevtic, Stefan D., et al.
Publicado: (2022)

COVID‐19 mRNA‐1273 vaccine induces production of vaccine‐induced immune thrombotic thrombocytopenia antibodies
por: Padmanabhan, Anand, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a07j9ldm3s9e6m82vtkt0i5pc3